These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38057555)

  • 1. A New Treatment for Recalcitrant Neurotrophic Keratopathy of Ocular Graft-Versus-Host Disease with Virus Infection.
    Qu Y; Peng R; Hu B; Ma S; Liu Z; Gu S; Hong J
    Ophthalmol Ther; 2024 Feb; 13(2):469-479. PubMed ID: 38057555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of neurotrophic keratopathy in patients with chronic ocular graft-versus-host disease.
    Singh RB; Yuksel E; Sinha S; Wang S; Taketani Y; Luznik Z; Yin J; Dohlman TH; Dana R
    Ocul Surf; 2022 Oct; 26():13-18. PubMed ID: 35843560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of recombinant human nerve growth factor treatment on corneal nerve regeneration in patients with neurotrophic keratopathy.
    Balbuena-Pareja A; Bogen CS; Cox SM; Hamrah P
    Front Neurosci; 2023; 17():1210179. PubMed ID: 37965220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Vivo Evaluation of Corneal Nerves and Epithelial Healing After Treatment With Recombinant Nerve Growth Factor for Neurotrophic Keratopathy.
    Mastropasqua L; Lanzini M; Dua HS; D' Uffizi A; Di Nicola M; Calienno R; Bondì J; Said DG; Nubile M
    Am J Ophthalmol; 2020 Sep; 217():278-286. PubMed ID: 32387431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II Randomized, Double-Masked, Vehicle-Controlled Trial of Recombinant Human Nerve Growth Factor for Neurotrophic Keratitis.
    Bonini S; Lambiase A; Rama P; Sinigaglia F; Allegretti M; Chao W; Mantelli F;
    Ophthalmology; 2018 Sep; 125(9):1332-1343. PubMed ID: 29653858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Topical Recombinant Human Nerve Growth Factor on Corneal Epithelial Regeneration in Refractory Epithelial Keratopathy.
    Dai X; Tunc U; Zhu X; Karakus S
    Ocul Immunol Inflamm; 2024 Mar; ():1-7. PubMed ID: 38427335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term clinical efficacy of topical treatment with recombinant human nerve growth factor in neurotrophic keratopathy: a novel cure for a rare degenerative corneal disease?
    Bruscolini A; Marenco M; Albanese GM; Lambiase A; Sacchetti M
    Orphanet J Rare Dis; 2022 Feb; 17(1):57. PubMed ID: 35172847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular pain in ocular graft-versus-host disease patients with neurotrophic keratopathy.
    Wang S; Singh RB; Yuksel E; Musayeva A; Sinha S; Taketani Y; Dohlman TH; Dana R
    Ocul Surf; 2022 Oct; 26():142-147. PubMed ID: 35948166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term restoration of corneal sensitivity in neurotrophic keratopathy after rhNGF treatment.
    Di Zazzo A; Varacalli G; Mori T; Coassin M
    Eur J Ophthalmol; 2022 Jan; 32(1):NP15-NP18. PubMed ID: 32854535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eight months follow-up of corneal nerves and sensitivity after treatment with cenegermin for neurotrophic keratopathy.
    Pedrotti E; Bonacci E; Chierego C; De Gregorio A; Cozzini T; Brighenti T; Caldarella G; Pastore G; Fasolo A; Marchini G
    Orphanet J Rare Dis; 2022 Feb; 17(1):63. PubMed ID: 35189948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chitosan-based thermosensitive hydrogel with long-term release of murine nerve growth factor for neurotrophic keratopathy.
    Wu J; Huang Y; Yu H; Li K; Zhang S; Qiao G; Liu X; Duan H; Huang Y; So KF; Yang Z; Li X; Wang L
    Neural Regen Res; 2024 Mar; 19(3):680-686. PubMed ID: 37721301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and instrumental assessment of the corneal healing in moderate and severe neurotrophic keratopathy treated with rh-NGF (Cenegermin).
    Roszkowska AM; Inferrera L; Aragona E; Gargano R; Postorino EI; Aragona P
    Eur J Ophthalmol; 2022 Nov; 32(6):3402-3410. PubMed ID: 35473440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical observation of recombinant human nerve growth factor in the treatment of neurotrophic keratitis.
    Hao M; Cheng Y; Wu J; Cheng Y; Wang J
    Int J Ophthalmol; 2023; 16(1):60-66. PubMed ID: 36659958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical Recombinant Human Nerve Growth Factor (Cenegermin) for Neurotrophic Keratopathy: A Multicenter Randomized Vehicle-Controlled Pivotal Trial.
    Pflugfelder SC; Massaro-Giordano M; Perez VL; Hamrah P; Deng SX; Espandar L; Foster CS; Affeldt J; Seedor JA; Afshari NA; Chao W; Allegretti M; Mantelli F; Dana R
    Ophthalmology; 2020 Jan; 127(1):14-26. PubMed ID: 31585826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical Spironolactone in the Treatment of Ocular Graft-Versus-Host Disease.
    Wong CW; Yang AA; Liu CY; Watsky MA; Lu X; Le HL; Yee RW
    Cureus; 2023 Sep; 15(9):e45136. PubMed ID: 37842497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes of corneal neurotization using sural nerve graft in neurotrophic keratopathy.
    Saini M; Kalia A; Jain AK; Gaba S; Malhotra C; Gupta A; Soni T; Saini K; Gupta PC; Singh M
    PLoS One; 2023; 18(11):e0294756. PubMed ID: 38015881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase IV Multicenter, Prospective, Open-Label Clinical Trial of Cenegermin (rhNGF) for Stage 1 Neurotrophic Keratopathy (DEFENDO).
    Hamrah P; Massaro-Giordano M; Schanzlin D; Holland E; Berdy G; Goisis G; Pasedis G; Mantelli F
    Ophthalmol Ther; 2024 Feb; 13(2):553-570. PubMed ID: 38175466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurotrophic keratopathy: Clinical presentation and effects of cenegermin.
    Bu JB; Gericke A; Pfeiffer N; Wasielica-Poslednik J
    Am J Ophthalmol Case Rep; 2022 Jun; 26():101488. PubMed ID: 35330588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical treatment with a new matrix therapy agent (RGTA) for the treatment of corneal neurotrophic ulcers.
    Aifa A; Gueudry J; Portmann A; Delcampe A; Muraine M
    Invest Ophthalmol Vis Sci; 2012 Dec; 53(13):8181-5. PubMed ID: 23150626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autologous serum application in the treatment of neurotrophic keratopathy.
    Matsumoto Y; Dogru M; Goto E; Ohashi Y; Kojima T; Ishida R; Tsubota K
    Ophthalmology; 2004 Jun; 111(6):1115-20. PubMed ID: 15177961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.